Literature DB >> 12962914

Cardiovascular function and circadian patterns in rats after area postrema lesions or prolonged food restriction.

Kathleen S Curtis1, Eric G Krause, Robert J Contreras.   

Abstract

The role of the area postrema (AP) in baseline cardiovascular function was evaluated by radio telemetry in rats with lesions of AP (APX), along with the effect of APX on circadian patterns of cardiovascular function and ingestive behavior. Despite lesion-induced hypophagia and body weight loss, APX did not affect circadian patterns of mean arterial pressure (MAP), heart rate (HR), or ingestion but did cause a substantial decrease (-60 bpm) in resting HR. The bradycardia was not attributable to weight loss, as resting HR in weight-matched controls, though decreased from baseline, was significantly greater than that in rats with APX. In weight-matched controls, HR increased slightly when weight returned to baseline; however, the bradycardia persisted in rats with APX. These results suggest that AP contributes to resting HR, independent of weight loss or changes in circadian patterns of HR or MAP.

Entities:  

Mesh:

Year:  2003        PMID: 12962914     DOI: 10.1016/s0304-3940(03)00739-0

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  Age-related impairment in choroidal blood flow compensation for arterial blood pressure fluctuation in pigeons.

Authors:  Anton Reiner; Nobel Del Mar; Yuri Zagvazdin; Chunyan Li; Malinda E C Fitzgerald
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-14       Impact factor: 4.799

2.  The cardiovascular response of normal rats to dual lesion of the subfornical organ and area postrema at rest and to chronic losartan.

Authors:  John P Collister; David B Nahey
Journal:  Brain Res       Date:  2009-09-16       Impact factor: 3.252

3.  Melatonin modulates baroreflex control via area postrema.

Authors:  Luciana A Campos; Jose Cipolla-Neto; Lisete C Michelini
Journal:  Brain Behav       Date:  2013-02-17       Impact factor: 2.708

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.